Log in to save to my catalogue

Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma

Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9c4170e5fac24876802eeade1e6638be

Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma

About this item

Full title

Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma

Publisher

England: BioMed Central Ltd

Journal title

Molecular cancer, 2023-01, Vol.22 (1), p.3-3, Article 3

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

This study aimed to validate whether infusion of GD2-specific fourth-generation safety-designed chimeric antigen receptor (4SCAR)-T cells is safe and whether CAR-T cells exert anti-glioblastoma (GBM) activity.
A total of eight patients with GD2-positive GBM were enrolled and infused with autologous GD2-specific 4SCAR-T cells, either through intr...

Alternative Titles

Full title

Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9c4170e5fac24876802eeade1e6638be

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9c4170e5fac24876802eeade1e6638be

Other Identifiers

ISSN

1476-4598

E-ISSN

1476-4598

DOI

10.1186/s12943-022-01711-9

How to access this item